Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $40.00 price target on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 28.16% from the stock’s previous close. A […]
Verity Asset Management Inc. purchased a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 7,211 shares of the biotechnology company’s stock, valued at approximately $234,000. A number of other institutional investors also recently bought and sold shares of CORT. FNY […]
ESS Tech And 2 Other Stocks Under $5 Insiders Are Buying - ESS Tech (NYSE:GWH) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
FY2025 Earnings Forecast for Corcept Therapeutics Incorporated Issued By HC Wainwright (NASDAQ:CORT) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.18 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Corcept Therapeutics (NASDAQ:CORT – […]